Par Drugs and Chemicals Limited — Board Meeting, 14-05-2026: Outcome of Board Meeting

Par Drugs & Chemicals board approved Q4/FY26 financial results and a Rs 90 Cr investment limit for liquid funds. Auditors noted SEBI's hold on a strategic business transfer but backed management's 'going concern' view.